Search Results 1811-1820 of 21482 for biopsy

1. Focal Segmental Glomerulosclerosis Clinical Trials - Mayo Clinic Research

   Another kidney biopsy will not be required as part of the study. Candidates must have failed or be intolerant of prior therapy for their kidney disease. The ...

2. Spinal cord tumor - Doctors and departments - Mayo Clinic

   esis surgery, Surgical biopsy, Tumor biopsy, Surgical stabilization of metastatic bone cancer, Tumor resection, Vertebral column resection, Pelvic tumor ...

3. A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) - Mayo Clinic

   ... biopsy to obtain the specimen. Must be a tumor block or approximately 15 unstained slides from biopsy or resection of primary tumor or metastasis.

4. Daniel M. Breitkopf, M.D. - Mayo Clinic Faculty Profiles

   Role of office hysteroscopy in obtaining endometrial biopsies; Minimally invasive methods for the treatment of abnormal uterine bleeding. Significance to ...

5. Low-Dose Selinexor and Choline Salicylate for the Treatment of Patients With Non-Hodgkin Lymphoma or Histiocytic/Dendritic Cell Neoplasms - Mayo Clinic

   - Biopsy-proven relapsed and/or refractory Non-Hodgkin or Hodgkin lymphoma or histiocytic/dendritic cell neoplasms - Relapsed is defined as a relapse that ...

6. Nephrotic Syndrome Study Network - Mayo Clinic

   Scheduled renal biopsy. Exclusion Criteria: Prior solid organ transplant; A clinical diagnosis of glomerulopathy without diagnostic renal biopsy; Clinical ...

7. Acute Liver Failure Clinical Trials - Mayo Clinic Research

   ... Biopsy Rochester, MN. We purpose of this study is to evaluate the ... biopsy for any liver disease. . Mayo Clinic Footer. Request Appointment · Give ...

8. A Study of the Outcomes of Natalizumab plus Standard Steroid Treatment for High Risk Acute Graft-Versus-Host Disease - Mayo Clinic

   Biopsy of acute GVHD target organ is strongly recommended but not required. Enrollment should not be delayed for biopsy or pathology results. Patients who ...

9. Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) - Mayo Clinic

   ... biopsy with associated lobular inflammation; Stage 3-4 fibrosis by Ishak score on a liver biopsy; Exclusion of other causes of liver disease including viral ...

10. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    ... biopsy is acceptable; Phase III study: evaluable disease - defined as RECIST 1.1 measurable disease OR non-measurable disease (defined as solid and/or cystic ...